Adjuvant Second-Dose Chemotherapy before Surgery for Patients with Locally Advanced Rectal Malignancy Is Not Beneficial: A Systematic Review and Meta-Analysis
Background. Preoperative chemoradiotherapy is the standard treatment for patients with locally advanced rectal cancer, although tumor responses vary widely; some patients may achieve a pathologic complete response rate (pCR) after chemoradiotherapy. Controversy exists with regard to the efficacy of...
Main Authors: | Min Chen, Xue Song, Liang-zhou Chen, Lin Xu, Yi-pu Lu, Jin-song Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2017/1373092 |
Similar Items
-
Optimize the dose of oxaliplatin for locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy followed by radical surgery and adjuvant chemotherapy
by: Hui Chang, et al.
Published: (2020-06-01) -
ADJUVANT CHEMOTHERAPY AFTER RECTAL CANCER CHEMORADIOTHERAPY
by: M. Yu. Fedyanin, et al.
Published: (2015-02-01) -
The impact of early adjuvant chemotherapy in rectal cancer.
by: Gyoung Tae Noh, et al.
Published: (2020-01-01) -
Post-chemoradiotherapy adjuvant chemotherapy of rectal cancer
by: E. V. Ledin, et al.
Published: (2018-08-01) -
Clinical Outcomes of Ileostomy Closure before Adjuvant Chemotherapy after Rectal Cancer Surgery: An Observational Study from a Chinese Center
by: Zhen Sun, et al.
Published: (2021-01-01)